Skip to content
healthcare.dev

tofacitinib

NDC 70771-1627, tofacitinib, tablet, film coated, extended release, from Zydus Lifesciences Limited.

Product NDC
70771-1627
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214264
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1627 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOFACITINIB CITRATE11 mg/1

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]

Package NDCNDC-11Package
70771-1627-37077116270330 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1627-3)
70771-1627-97077116270990 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70771-1627-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ac0b26d5-1352-42ff-b5ea-3eb02d8508a4

Use it

Look up 70771-1627 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1627 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1627. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.